Personalized prescription of chemotherapy based on assessment of mRNA expression of BRCA1, RRM1, ERCC1, TOP1, TOP2α, TUBβ3, TYMS, and GSTP1 genes in tumors compared to standard chemotherapy in the treatment of non-small-cell lung cancer

Objectives: A growing body of evidence suggests the important role of chemosensitive gene expression in the prognosis of patients with lung cancer. However, studies on combined gene expression assessments for personalized prescriptions of chemotherapy regimens in patients have not yet been conducted...

Full description

Bibliographic Details

Published in:	Journal of personalized medicine Vol. 12, № 10. P. 1647 (1-13)
Other Authors:	Tsyganov, Matvey M., Rodionov, Evgeniy O., Ibragimova, Marina K., Miller, Sergey V., Cheremisina, Olga V., Frolova, Irina G., Tuzikov, Sergey A., Litvyakov, Nicolay V.
Format:	Article
Language:	English
Subjects:	немелкоклеточный рак легкого адъювантная химиотерапия экспрессия генов индивидуализированная химиотерапия выживаемость без метастазов общая выживаемость статьи в журналах
Online Access:	http://vital.lib.tsu.ru/vital/access/manager/Repository/koha:001008792 Перейти в каталог НБ ТГУ